Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Frequently asked questions
What sector does Lonza Group AG (LONN) operate in?
Lonza Group AG belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is Lonza Group AG (LONN) current stock price?
As of the latest data, Lonza Group AG stock price is CHF 572.80, with a previous close of CHF 566.20. Lonza Group AG gained CHF 6.60 in the last trading session, representing a 1.17% increase.
What is Lonza Group AG (LONN) current market capitalization?
Lonza Group AG market cap is approximately 40.01 billion.
What is Lonza Group AG (LONN) Earnings Per Share (EPS)?
The trailing EPS is CHF 15.51, and the forward EPS is CHF 21.98.
What is Lonza Group AG (LONN) Price-to-Earnings (P/E) ratio?
Lonza Group AG current P/E ratio is 36.93, with a forward P/E of 26.06.
What is Lonza Group AG (LONN) EBITDA?
Lonza Group AG EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 1.14 billion.
Does Lonza Group AG (LONN) pay dividends?
Yes. Lonza Group AG pays annual dividends with an annualized yield of 0.87% and an estimated annual payout of CHF 5.00 per share.
When is the next ex-dividend date for Lonza Group AG (LONN)?
The next ex-dividend date is scheduled for May 12, 2027.
When is Lonza Group AG (LONN) next earnings report?
Lonza Group AG is expected to release its next earnings report on June 30, 2026.
What is Lonza Group AG (LONN) beta (volatility) score?
Lonza Group AG has a beta of 0.839, meaning its volatility is roughly in line with the market.
